University of Zaragoza

Asia Flow Chemistry Conference 2023: Revolutionizing Chemistry - Exploring Cutting-edge Developments (Tokyo, Japan - October 5-6, 2023)

Retrieved on: 
Monday, September 18, 2023
University of Southern California, Yokohama National University, University, Associate professor, Collegiality, University of Zaragoza, Convention, HF, Postgraduate education, SF4, IIT Bombay, Diaphragm, EPIC, Research, Polytechnique Montréal, Flow chemistry, University of Graz, Chemical substance, Chemistry, Department of Chemical Engineering, Imperial College London, Chemical engineering, Conference, Management, Film industry, Furniture, Science, Catalysis, F2, Engineering, Professor

The Flow Chemistry Asia 2023 Conference will be held on October 5-6, 2023 at the Nikko Naritaright at Tokyo-Narita Airport.This annual event brings together researchers from around the world and across Japan and features academic presentations, industry presentations, an exhibit hall with companies from around the world plus extensive networking opportunities.This conference features 4-co-located tracks enabling extensive scientific exchanges and networking across disciplines -- your registration provides access to all conference tracks, all content and all networking events.In addition to an exhibit hall, the conference also includes poster sessions and encourages attendees to submit posters as a means to showcase their research and engage with the participants. 

Key Points: 
  • DUBLIN, Sept. 18, 2023 /PRNewswire/ -- The "Flow Chemistry Asia 2023" conference has been added to ResearchAndMarkets.com's offering.
  • The Flow Chemistry Asia 2023 Conference will be held on October 5-6, 2023 at the Nikko Naritaright at Tokyo-Narita Airport.
  • This conference features 4-co-located tracks enabling extensive scientific exchanges and networking across disciplines -- your registration provides access to all conference tracks, all content and all networking events.
  • 2nd our AI software which further minimizes pulsation thru AI learning of the pulsation patterns and adjusting the motor speed.

Promontory Therapeutics to Present Research on PT-112 in Prostate Cancer at the 34th EORTC-NCI-AACR Symposium

Retrieved on: 
Wednesday, October 12, 2022
Merck Serono, ASH, Biochemistry, Congress, American Association for Cancer Research, Therapy, University of Zaragoza, Patient, B cell, European Organisation for Research and Treatment of Cancer, Research, Orphan drug, University, ICD, Treatment, Tumor microenvironment, Trial of the century, AACR, NSCLC, National Cancer Institute, Development of the human body, American Association, EORTC, Cell biology, Prostate cancer, Safety, Merck Group, National, ESMO, Immunogenic cell death, Damage-associated molecular pattern, César Award for Best Poster, NCI, Large-cell lung carcinoma, Pharmaceutical industry, Cancer

PT-112 represents a highly potent inducer of this immunological form of cancer cell death.

Key Points: 
  • PT-112 represents a highly potent inducer of this immunological form of cancer cell death.
  • The PD-L1 combination Phase 2a study is ongoing in a dose confirmation cohort of non-small cell lung cancer (NSCLC) patients.
  • Promontory Therapeutics Inc. is a privately held, clinical stage pharmaceutical company focused on small molecule immunotherapy.
  • To learn more about Promontory Therapeutics, visit the company's website here .

Phosplatin Therapeutics Presents on PT-112 at the 2022 AACR Annual Meeting: Selective Intracellular Effects Leading to Immunogenic Cell Death (ICD) in Prostate Cancer Cell Models

Retrieved on: 
Thursday, March 10, 2022
CRADA, Safety, Drug resistance, AACR, ICD, Large-cell lung carcinoma, Family, B cell, Trial of the century, American Academy, University, Congress, University of Zaragoza, ESMO, Research, Development of the human body, Therapy, Cell biology, Merck Group, César Award for Best Poster, NCI, Prostate cancer, Immunogenic cell death, Tumor microenvironment, Biochemistry, Cancer, Toxicity, Patient, Merck Serono, Damage-associated molecular pattern, ASH, PD-L1, NSCLC, Pharmaceutical industry

The presentation will be held at the 2022 AACR Annual Meeting taking place on April 8-13, 2022 in New Orleans.

Key Points: 
  • The presentation will be held at the 2022 AACR Annual Meeting taking place on April 8-13, 2022 in New Orleans.
  • The work to be presented was generated by the company under a research collaboration with the Anel Lab at the University of Zaragoza, Spain.
  • The characterization of intracellular pathways leading to ICD and the adaptive immune response is an important research aim of the company, and a related peer-reviewed manuscript is under preparation.
  • PT-112 may represent the best-in-class inducer of this immunological form of cancer cell death.

Roberto Mazzara to Donate 5% of Proceeds from Santa Maria Bell Auction to the American Cancer Society

Retrieved on: 
Thursday, October 21, 2021
CASA, American Cancer Society, House, ACS, University, Disease, General Archive of the Indies, White House National Trade Council, University of Zaragoza, Regional integration, Ownership, Auction

The Santa Maria bell will be auctioned off on November 18 in Miami.

Key Points: 
  • The Santa Maria bell will be auctioned off on November 18 in Miami.
  • The bell was discovered by former Italian naval officer and underwater salvage expert Roberto Mazzara in 1994 off the coast of northern Portugal.
  • Mazzara believes that the auction "will be a wonderful opportunity to give the world of collectors access to this unique piece."
  • Five percent of the auction's proceeds will be donated to the American Cancer Society (ACS).